Clinical trial
A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management of Depression
NCT02189057 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pharmacokinetic/Pharmacodynamic Genetic Variation Treatment Algorithm Versus Treatment As Usual for Management of Depression
- Lead sponsor
- Mayo Clinic
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2014
- Completion date
- October 19, 2018
- Enrollment
- 160 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bipolar, depression, mood disorder